International Stem Cell (ISCO) EPS (Basic) Growth (3y) (2013 - 2026)
Powered by 
Analysis
International Stem Cell (ISCO) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.37 Bn | 112.79 Mn | 51.67% |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn | 39.50% |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | 32.71% |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 44.39% |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn | 34.14% |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn | -31.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.50% |
| Dec 31, 2025 | -143.45% |
| Sep 30, 2025 | 27.74% |
| Jun 30, 2025 | 228.65% |
| Mar 31, 2025 | -205.25% |
| Dec 31, 2024 | 26.67% |
| Sep 30, 2024 | 42.01% |
| Jun 30, 2024 | 28.77% |
| Mar 31, 2024 | 30.45% |
| Dec 31, 2023 | 17.24% |
| Sep 30, 2023 | 46.94% |
| Jun 30, 2023 | 31.68% |
| Mar 31, 2023 | 59.53% |
| Dec 31, 2022 | 26.20% |
| Sep 30, 2022 | -378.84% |
| Jun 30, 2022 | 85.73% |
| Mar 31, 2022 | 79.06% |
| Dec 31, 2021 | 33.90% |
| Sep 30, 2021 | -83.65% |
| Jun 30, 2021 | 3.27% |